A vast number of compounds identified through these methods have already made significant strides in treating diseases such as viral infections and cancer, including HIV inhibitors, tyrosine kinase inhibitors for chronic myeloid leukemia, and ALK inhibitors for pancreatic cancer, among others [[34], [35], [36], [37]]. The gene discussed is ALK; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.